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M1 and M2 macrophages derived from
THP-1 cells differentially modulate the
response of cancer cells to etoposide
Marie Genin1, Francois Clement1, Antoine Fattaccioli1, Martine Raes1 and Carine Michiels2*
Abstract
Background: Tumor associated macrophages (TAMs) are present in high density in solid tumors. TAMs share many
characteristics with alternatively activated macrophages, also called M2. They have been shown to favor tumor
development and a role in chemoresistance has also been suggested. Here, we investigated the effects of M2 in
comparison to M1 macrophages on cancer cell sensitivity to etoposide.
Methods: We set up a model of macrophage polarization, starting from THP-1 monocytes differentiated into
macrophages using PMA (Phorbol 12-myristate 13-acetate). Once differentiated (M0 macrophages), they were
incubated with IL-4 and IL-13 in order to obtain M2 polarized macrophages or with IFN-gamma and LPS for
classical macrophage activation (M1). To mimic the communication between cancer cells and TAMs, M0, M1 or M2
macrophages and HepG2 or A549 cancer cells were co-cultured during respectively 16 (HepG2) or 24 (A549) hours,
before etoposide exposure for 24 (HepG2) or 16 (A549) hours. After the incubation, the impact of etoposide on
macrophage polarization was studied and cancer cell apoptosis was assessed by western-blot for cleaved caspase-3
and cleaved PARP-1 protein, caspase activity assay and FACS analysis of Annexin V and PI staining.
Results: mRNA and protein expression of M1 and M2 markers confirmed the polarization of THP-1-derived
macrophages, which provide a new, easy and well-characterized model of polarized human macrophages.
Etoposide-induced cancer cell apoptosis was markedly reduced in the presence of THP-1 M2 macrophages, while
apoptosis was increased in cells co-cultured with M1 macrophages. On the other hand, etoposide did not influence
M1 or M2 polarization.
Conclusions: These results evidence for the first time a clear protective effect of M2 on the contrary to M1
macrophages on etoposide-induced cancer cell apoptosis.
Keywords: THP-1, Macrophage polarization, Cancer cells, Co-culture, Apoptosis
Background
Macrophages constitute a heterogeneous population of
myeloid cells of the innate immune system involved in
several processes in physiological as well as in pathological
conditions. They are particularly active in inflammation
and infection. Under such conditions, blood monocytes
are recruited into the tissue where they differentiate into
macrophages [1]. Macrophages display a high plasticity,
which allows them to adapt their phenotype in response
to different environmental stimuli [2]. Two major
polarization states have been described for macrophages,
the classically activated type 1 (M1) and the alternatively
activated type 2 (M2). In 2002, Mantovani et al. [3] de-
scribed these two macrophage phenotypes as extremes of
a continuum of functional states. Classical activation of
macrophages occurs following injury or infection. Macro-
phages are classically activated in vitro using bacterial cell
wall components (such as LPS) and IFN-γ or TNF-α. M1
macrophages are characterized by the production of pro-
inflammatory cytokines like TNF-α, IL-1β, IL-6 and IL-12.
They also produce high levels of reactive oxygen and
nitrogen species [4]. However, the expression of iNOS,
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the enzyme responsible for NO production by M1
macrophages, is specific to murine macrophages and is
absent in human macrophages [5]. M2 macrophage
polarization can be induced by different stimuli: IL-4 and/
or IL-13, immune complexes and toll-like receptor, IL-1
receptor ligands or IL-10 [6]. Alternatively activated mac-
rophages polarized by IL-4 and IL-13 are characterized by
a limited production of pro-inflammatory cytokines, but
they secrete anti-inflammatory cytokines like IL-10,
CCL18 and CCL22. They are also characterized by the ex-
pression of several receptors like the mannose receptor
CD206 (or MRC1), the scavenging receptor CD163,
dectin-1 and DC-SIGN (Dendritic cell-specific intercellu-
lar adhesion molecule-3-grabbing non-integrin) [7, 8].
Solid tumors comprise not only malignant cells but
also stromal host cells such as adipocytes, fibroblasts
and hematopoietic cells, which are recruited from the
blood vessels. Among these tumor infiltrated immune
cells, macrophages are the most abundant, called tumor
associated macrophages (TAMs) [9]. Many studies have
shown that in malignant tumors, macrophages predom-
inantly exhibit a M2-like phenotype [3]. M2 macro-
phages, on the contrary to M1 cells that are pro-
inflammatory and cytotoxic, are immunosuppressive
and favor angiogenesis and tissue repair [10]. Many
studies have shown that tumor associated M2 macro-
phages improve tumor cell growth and survival and
stimulate angiogenesis and metastases. In 2011, Shree
et al. showed that cathepsin-expressing macrophages
protect breast cancer cells from cell death induced by
several chemotherapeutic drugs like taxol or etoposide
[11]. Very recently, Mantovani and Allavena published
a review summarizing the actual knowledge on the ef-
fect of anticancer therapies on TAMs [12]. However, a
better understanding of this chemoprotective effect is
still needed in order to design more efficient thera-
peutic strategies.
In order to study how macrophages could modulate
tumor cells and in particular the tumor cell response to
chemotherapeutic agents, we first set up a new and con-
venient model of human macrophage polarization. Mac-
rophages were differentiated starting from the human
monocytic cell line THP-1. Once differentiated in the pres-
ence of PMA, they can be polarized into M1 or M2 macro-
phages that express markers similarly to polarized
macrophages obtained from freshly isolated monocytes.
When HepG2 hepatoma cells or A549 lung adenoma cells
were co-cultured with THP-1 M1 or M2 macrophages, they
responded differentially to etoposide. In the presence of
THP-1 M1 macrophages, the apoptosis of cancer cells in-
duced by etoposide increased. On the opposite, M2 THP-1
macrophages were protective. This is the first demonstra-
tion that THP-1 polarized macrophages display functions
similar to the ones described for polarized TAMs.
Methods
Cell culture
Human monocytic THP-1 cells were maintained in culture
in Roswell Park Memorial Institute medium (RPMI 1640,
Invitrogen) culture medium containing 10 % of heat inacti-
vated fetal bovine serum (Invitrogen) and supplemented
with 10 mM Hepes (Gibco, #15630-056), 1 mM pyruvate
(Gibco, #11360-039), 2.5 g/l D-glucose (Merck) and 50 pM
ß-mercaptoethanol (Gibco; 31350–010). THP-1 monocytes
are differentiated into macrophages by 24 h incubation with
150 nM phorbol 12-myristate 13-acetate (PMA, Sigma,
P8139) followed by 24 h incubation in RPMI medium.
Macrophages were polarized in M1 macrophages by incu-
bation with 20 ng/ml of IFN-γ (R&D system, #285-IF) and
10 pg/ml of LPS (Sigma, #8630). Macrophage M2
polarization was obtained by incubation with 20 ng/ml of
interleukin 4 (R&D Systems, #204-IL) and 20 ng/ml of
interleukin 13 (R&D Systems, #213-ILB). HepG2 and A549
cells were respectively cultivated in Dulbecco’s modified
Eagle's minimal essential medium (DMEM medium 1 g
glucose/l) (Gibco) and Minimum Essential Medium Eagle
medium (MEM) (Gibco), both containing 10 % fetal bovine
serum. In the co-culture experiments, THP-1 monocytes
were differentiated in 6 Transwell inserts (membrane pore
size of 0.4 μm, Corning, #3450). Macrophages and HepG2
cells were co-cultured in CO2 independent medium supple-
mented with 0.5 mM L-glutamine (Sigma, # G3126) and
3.75 g/l of D-glucose (Sigma, #50-99-7) for 16 h before be-
ing incubated with or without 50 μM etoposide (Sigma,
#E1383) for 24 h. Macrophages and A549 cells were co-
cultured in CO2 independent medium supplemented with
0.5 mM L-glutamine and 2.5 g/l of D-glucose for 24 h be-
fore being incubated with or without 50 μM etoposide for
16 h. In the monoculture experiments, 0.8 x 106 THP-1
monocytes were differentiated and polarized in 6 well
plates. Next, they were incubated in CO2 independent
medium supplemented with 0.5 mM L-glutamine (Sigma, #
G3126) and 3.75 g/l of D-glucose (Sigma, #50-99-7) for
16 h before being incubated with or without 50 μM etopo-
side (Sigma, #E1383) for 24 h.
Immunofluorescence labeling and confocal microscopy
THP-1 monocytes were seeded at 100 000 cells/well in 24-
well plates containing a coverslip and were differentiated as
described here above. Undifferentiated monocytes were at-
tached on coverslips by drying a PBS drop containing 100
000 cells. For labeling, cells were fixed for 10 min with
paraformaldehyde 4 % in cold PBS, washed three times
with 2 % PBS–BSA (bovine serum albumin) and incubated
overnight at 4 °C with the primary antibody 1:100 diluted
in 2 % PBS-BSA: anti-CD68 (KP1) from Abcam (ab955),
anti-CD71 (H300) from Santa Cruz (sc-9099), anti-CD36
(H300) from Santa Cruz (sc-9154), anti-CD14 (1H5D8)
from Abcam (ab181470). Cells were washed three times
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with 2 % PBS–BSA and then incubated for 1h with the sec-
ondary antibody. Alexa Fluor-488-conjugated anti-rabbit
IgG antibody (Molecular Probes, #A11034) was used at
1/1000 dilution. Cells were then washed three times
with PBS, the coverslips were mounted in Mowiol (Sigma)
and observed with a confocal microscope (SP5, Leica).
Cell viability (MTT assay)
THP-1 monocytes were seeded at 180 000 cells/well in 24
well plates and differentiated in macrophages as described.
After incubation with IFN-γ ± LPS, cells were incubated 2 h
with 500 μl of MTT reagent (2.5 mg/ml of PBS, Sigma
#M2128) in the CO2 incubator. The media were then re-
moved and 1 ml of lysis buffer (SDS 30 %/N,N-dimethyl-
formamide 2:1 pH 4.7) was added per well. Plates were in-
cubated at 37 °C and gently shaked at 70 rpm for 1 h. The
absorbance was then measured at 570 nm.
RT-qPCR
After the incubation, total RNA was extracted using the
RNeasy mini kit and DNase protocol (Qiagen, #74104).
mRNA contained in 2 μg total RNA was reverse tran-
scribed using Transcriptor first strand cDNA synthesis
kit (Roche, #4379012001). Amplification reaction assays
contained SYBRGreen PCR Master Mix (Applied Biosys-
tem, #4309155) and primers (IDT, 300 nM). RPS9 (40S
ribosomal protein S9) was used as the reference gene for
normalization and mRNA abundance was quantified
using the threshold cycle method.
ELISA
Cytokine secretion in the culture medium was assayed
using an ELISA kit according to the procedure recom-
mended by the supplier (CXCL10 (R&D System, #DIP100),
IL-6 (R&D System, D6050), IL-10 (R&D System, D1000B),
CCL18 (Abnova, #KA1757)).
Results are expressed in pg of cytokine normalized per
μg of proteins assayed by the Pierce method after cell
lysis using 60 μl of mammalian protein extraction re-
agent (78501 from Thermo Scientific).
Analysis of CD206 plasma membrane expression by flow
cytometry
THP-1 monocytes were seeded in T25 flask at 2.5 × 106
cells/T25 and differentiated with PMA. After incubation
with or without IL-4 and IL-13, cells were washed with
cold PBS and detached with EDTA 5 mM. Cold PBS
containing 5 % human heat inactivated serum (his) and
0.1 % NaN3 was added in the flasks and the cell suspen-
sion put in FACS tubes. Cells were counted and 0.5 × 106
cells were resuspended in a total of 1 ml of PBS 5 % his
0.1 % NaN3. Cell suspension was centrifuged 5 min at
200 g and 4 °C and the pellet resuspended with 1 ml of PBS
5 % his 0.1 % NaN3. This washing step was performed
twice. The pellet was next resuspended with human truS-
tain FcX (BioLegend, #422301) diluted 20 x in PBS. A total
volume of 50 μl was used for resuspension. The suspension
was then incubated at room temperature for 10 min. Cells
were centrifuged 5 min at 200 g and 4 °C. The pellet was
resuspended with 50 μl of primary anti-CD206 antibody di-
luted 5 times in PBS 5 % his 0.1 % NaN3 and incubated
30 min at 4 °C. Cells were also incubated with the control
isotype corresponding to each primary antibody. Primary
antibodies are PE (Phycoerythrin) mouse anti-human
CD206 (BD Pharmingen, #555954) and PE mouse IgG1 κ
isotype control (BD Pharmingen #555749). After incuba-
tion, PBS 5 % his 0.1 % NaN3 was added and the suspen-
sion centrifuged 5 min at 200 g and 4 °C. Three washes
with PBS 5 % his 0.1 % NaN3 were next performed. The
pellet was resuspended with 2 % paraformaldehyde (in cold
PBS) and incubated 20 min at 4 °C. Suspension was centri-
fuged 5 min at 200 g 4 °C and the pellet resuspended with
glycine 0.1 M (in cold PBS) and incubated 10 min at 4 °C.
A last centrifugation of 5 min at 200 g and 4 °C was per-
formed before cell resuspension in 1 ml of PBS 5 % his
0.1 % NaN3. Cells were analyzed by flow cytometry with a
FACScalibur (BD Biosciences).
Western blotting
Cells were seeded in 6 well plates (Costar; 250000 HepG2
cells/well and 125000 A549 cells/well) 1 day before incuba-
tion with macrophages. After the incubation, proteins were
extracted and PARP-1 and caspase-3 protein abundance
was assessed by western blotting as described previously
[13]. Primary antibodies are rabbit anti-caspase-3 antibody
(Cell Signaling, #9662) and mouse anti-PARP1 antibody
(BD Pharmingen, #551025). Primary antibodies mouse
anti-β-actin (Sigma, #A5441) or mouse anti-α-tubulin
(Sigma, # T5168) were used for normalization. IRDye
800CW-conjugated goat anti-rabbit antibody (H + L; Licor,
#926-32211), IRDye 800CW-conjugated goat anti-mouse
antibody (H + L; Licor, #926-32210) and IRDye 680LT-
conjugated goat anti-mouse antibody (H + L; Licor, # 926–
68020) were used as secondary antibodies. Quantitative
analysis of fluorescence intensity was measured using the
Odyssey Classic Infrared Imaging System (Licor).
Caspase activity assay
The fluorogenic substrate Ac-DEVD-AFC was used to
measure caspase-3 and caspase-7 activity according to
Lozano et al. [14]. Cell extracts were prepared as described
by Wellington et al. [15]. HepG2 or A549 cells were seeded
in 6 well plates (Costar; 250000 HepG2 cells/well- 125000
A549 cells/well) 1 day before incubation with macrophages.
After the incubation, proteins were extracted and caspase
activity was measured in the different samples as described
previously [13].
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Flow cytometry analysis of Annexin V/Propidium iodide
staining
HepG2 or A549 cells were seeded in 6 well plates (Costar;
250000 HepG2 cells/well- 125000 A549 cells/well) 1 day
before incubation with macrophages. After the incubation,
tumor cells were harvested with trypsin/EDTA and stained
using FITC Annexin V apoptosis Detection Kit I (BD Phar-
mingen #556547). Results were analyzed by flow cytometry
(FACSCalibur, BD).
Statistical analysis
Statistical analyses were performed using the Sigma Stat
software. For some analyses, values did not follow a
Gaussian distribution. In order to deal with this absence
of normality, statistical analyses were performed on log-
transformed data. In order to facilitate interpretation,
untransformed data are shown.
Results and discussion
Monocyte differentiation into macrophages
Human THP-1 monocytes were differentiated into
macrophages by an incubation in the presence of phor-
bol 12-myristate 13-acetate (PMA). Different PMA
concentrations and incubation times were tested (data
not shown). A 24 h incubation in the presence of 150
nM PMA followed by 24 h in control medium was
finally selected as differentiation protocol. Cells be-
came adherent and the expression of recognized
macrophage markers, CD68 (cluster of differentiation
68) [16], CD71 [17] and CD36 [18], analyzed by im-
munofluorescence staining to confirm the monocyte-
to-macrophage differentiation, also clearly increased.
The expression of CD14, which decreases with macro-
phage differentiation [19], was also studied and con-
firmed the differentiation (Fig. 1).
Fig. 2 Effects of IFN-γ and/or LPS on THP-1 macrophage viability after 16 or 24 h of incubation. THP-1 macrophages were incubated in RPMI
medium with IFN-γ (20, 50 or 100 ng/ml) alone or in combination with LPS at different concentrations. After 16 and 24 h of incubation, cell
viability was measured by a MTT assay. Results are expressed as means ± 1 S.D. (n = 3). Statistical analysis was carried out with a two-way ANOVA
test followed by a Holm-Sidak post-test. * or ***: significantly different from the corresponding control (Ctrl) respectively with p < 0.05 or 0.001
Fig. 1 THP-1 monocyte differentiation in macrophages. THP-1 cells
were incubated 24 h in the presence of 150 nM PMA and then in
RPMI medium during 24 h. Cells were then fixed and immunolabeled
for CD14, CD68, CD71 or CD36 using specific antibodies (green). Nuclei
were detected with To-pro3 (blue)
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THP-1 polarization into pro-inflammatory M1
macrophages
The classical protocol for M1 polarization is to incu-
bate macrophages in the presence of IFN-γ alone or in
combination with LPS [6], in general for 24 h. While
IFN-γ is used at 20 ng/ml in most studies the LPS con-
centration varied from 10 ng to 1 μg/ml according to
the reports [20, 21].
Based on the literature, we tested different concentra-
tions of LPS, varying from 1 to 100 ng/ml, combined
with 20 ng/ml of IFN-γ and we incubated THP-1
macrophages during 16 or 24 h. We observed a high
cytotoxicity, which increased with the LPS concentra-
tion: cell viability, measured by a MTT assay, decreased
from 100 % in control cells to 65 % after 24 h incubation
with 10 ng/ml of LPS + 20 ng/ml of IFN-γ. No toxicity
was observed with IFN-γ alone (Fig. 2). The cytotoxicity
induced by LPS on macrophages has been already de-
scribed [22, 23]. To reduce the LPS induced cytotoxicity,
Hirose and colleagues worked with lower LPS concen-
trations and incubated macrophages for M1 polarization
with 10 pg/ml of LPS + 20 ng/ml INF-γ for 18 h [22].
Fig. 3 M1 macrophage marker expression. THP-1 macrophages were incubated with IFN-γ (20, 50, 100 ng) and/or LPS 10 pg/ml during 24 h. (a)
mRNA expression of M1 macrophage markers was studied by RT-qPCR and normalized by RPS9 expression. Results are expressed as means ± 1 S.D.
(n = 3). (b) IL-6 and CXCL10 secretion in culture medium was measured by ELISA. Results are expressed as means ± 1 S.D. (n = 3). Statistical
analysis was carried out with a one-way ANOVA test followed by a Holm-Sidak post-test. NS: not significantly different. *, ** or ***: significantly
different from the corresponding control (Ctrl) respectively with p < 0.05, 0.01 or 0.001; ###: significantly different with p < 0.001. Statistical analyses
were performed on non-transformed data for TNF-α (a), IL-1ß (a), IL-6 (b) and CXCL10 (b) and on log-transformed data for IL-6 (a), CXCL10 (a), CD80
(a) and HLD-DR (a)
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We thus incubated M0 THP-1 macrophages during 16
or 24 h with 10 pg/ml LPS + 20 ng/ml IFN-γ. In these
conditions, the cell viability was not affected after 16 h
incubation and only slightly (93 % cell viability) after
24 h incubation (Fig. 2).
Macrophage M1 polarization was then assessed by
measuring the expression of several classical M1
markers: TNF-α, IL-1β, IL-6 and CXCL10, which are
pro-inflammatory cytokines, and CD80 and HLA-DR,
two membrane receptors, both at the mRNA level
Fig. 4 M2 macrophage marker mRNA expression. (a) THP-1 macrophages were incubated during 24 h either with IL-4 and IL-13 (20 ng/ml each)
or with IFN-γ 20 ng/ml and LPS 10 pg/ml and mRNA expression of M2 macrophage markers was studied by RT-qPCR and normalized by RPS9
expression. Results are expressed as means ± 1 S.D. (n = 3). (b) THP-1 macrophages were incubated with IL-4 and IL-13 (20 ng/ml each) during 24,
48 or 72 h and mRNA expression of M2 macrophage markers was studied by RT-qPCR and normalized by RPS9 expression. Results are expressed
as means ± 1 S.D. (n = 3). Statistical analysis was carried out with a one-way ANOVA for figure A and a two-way ANOVA for figure B, followed by a
Holm-Sidak post-test. NS: not significantly different. *, ** or ***: significantly different from the corresponding control (Ctrl) respectively with p < 0.05,
0.01 or 0.001; ###: significantly different with p < 0.001. Statistical analyses were performed on log-transformed data for CD206 (b), fibronectin (b) and
CCL18 (b)
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using RT-qPCR (Fig. 3a) and at the protein level by
ELISA (for IL-6 and CXCL10) (Fig. 3b). An increased
pro-inflammatory marker expression profile was obtained
by incubation with IFN-γ combined with 10 pg/ml of LPS
in comparison to IFN-γ alone. TNF-α and IL-1β were
expressed in control M0 macrophages, but their expression
decreased after 24 h in control medium. This could be due
to PMA used for monocyte-to-macrophage differentiation,
which has been described to up-regulate their expression
[24]. On the other hand, their expression was highly in-
creased in macrophages incubated in the presence of LPS
and IFN-γ.
We also checked the expression at the mRNA level of
several M2 markers (CD206, CD163, fibronectin, IL-10,
CCL18 and CCL22) in M1 macrophages, but in our con-
ditions, we observed no significant expression of these
genes (Fig. 4a). This was not the case when higher LPS
concentrations were used for macrophage polarization. In-
deed, after 24 h of incubation with 10 ng/ml of LPS +
20 ng/ml IFN-γ, the mRNA abundance of CCL18 increased
(data not shown). CCL18 has been frequently described as
a M2 macrophage marker, induced by IL-4, IL-13 and IL-
10 [6, 25]. In 2013, Chanput et al. [26] published a model
of THP-1 macrophage polarization in M1 and M2 macro-
phages. To polarize macrophages in M1 cells, they incu-
bated cells with 20 ng/ml IFN-γ plus 1 μg/ml LPS. In
these conditions, they measured higher levels of expres-
sion for several M2 macrophage markers (IL-10, CCL17,
CCL18) in M1 macrophages than in M2 (polarized after
24 h incubation with 20 ng/ml IL-4). This result con-
firms our hypothesis that the incubation of THP-1
macrophages with high LPS concentrations might in-
duce an unspecific expression of M2 macrophage
markers in pro-inflammatory macrophages.
In conclusion, incubation of THP-1 macrophages with
IFN-γ 20 ng/ml and LPS 10 pg/ml during 24 h induces
their polarization into M1 macrophages.
THP-1 polarization into anti-inflammatory M2
macrophages
Macrophage polarization into alternatively activated mac-
rophages, also called M2 cells, is induced in vivo and in
vitro by IL-4 and IL-13 stimulation [6]. In most of the
studies in which murine or human primary macro-
phages were polarized into M2 macrophages, incuba-
tions of 16 or 24 h with 20 ng/ml of IL-4 alone or
combined with 20 ng/ml of IL-13 have been generally
used [20, 22, 23].
We incubated M0 THP-1 macrophages with IL-4 and IL-
13 at a concentration of 20 ng/ml during 24, 48 or 72 h.
The M2 phenotype was characterized by studying the
mRNA and protein abundance of several M2 markers:
CD206, CD163, fibronectin, IL-10, CCL18 and CCL22.
After 24 h incubation, the expression of CD206, fibronectin
and IL-10 was slightly increased whereas CD163, CCL18
and CCL22 expression was unchanged. If the incubation
Fig. 5 Cell surface CD206 expression by M2 macrophages. THP-1 macrophages were incubated during 24 or 72 h with control medium with or
without IL-4 and IL-13. CD206 protein expression on macrophages was analyzed by flow cytometry with a specific antibody coupled to PE. Two
controls were performed: some cells were unstained and others stained with a control isotype. The graph presents the histogram median of one
of each sample
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time with IL-4 and IL-13 was increased to 48 and even fur-
ther to 72 h, the mRNA abundance of all M2 markers was
much higher (Fig. 4b). The expression pattern of CD206,
IL-10 and CCL18 was confirmed at the protein level by
FACS analysis for CD206 (Fig. 5) and by ELISA for IL-10
and CCL18 (Fig. 6). No expression of any M1 macrophage
marker was evidenced in M2 polarized macrophage after
72 h incubation with IL-4 and IL-13 (data not shown).
When compared to results obtained with primary
macrophages differentiated from blood-isolated mono-
cytes, the polarization of macrophages derived from
THP-1 seems to require a longer incubation time (data
not shown, [20]). Indeed, Martinez and colleagues
measured a high CCL18 mRNA expression in primary
macrophages incubated 16 h with 20 ng/ml of IL-4
(M1:M2 ratio of −19) while 72 h of incubation with IL-
4 and IL-13 were required to induce CCL18 expression
and to detect a secretion of CCL18 in the culture
media of THP-1-derived M2 macrophages.
Effect of M1 and M2 macrophages on cancer cell
apoptosis
In order to study the effects of M1 (pro-inflammatory
and anti-tumoral) and M2 (anti-inflammatory and pro-
tumoral) THP-1 macrophages on cancer cell response to
a chemotherapeutic agent, each cell population was co-
cultured with HepG2 (human hepatoma) cells in indirect
contact using Transwell inserts. Monocytes were seeded
on inserts made of a membrane with 0.4 μm pores,
which allowed the exchange of soluble factors but not
the trans-migration of cells. THP-1 monocyte differenti-
ation was launched at different days for M2, M1 and M0
macrophages in order to obtain differentiated and polar-
ized macrophages on the same day. 250,000 HepG2 cells
were seeded in 6 well plates 24 h before the end of
macrophage polarization. This cell density was chosen in
order to have a 1:1 ratio between tumor cells and mac-
rophages co-cultured in serum free medium. Serum free
medium was used because serum protects HepG2 cells
against apoptosis induced by etoposide (data not shown).
After 16 h of co-culture, the two cell populations were
incubated in the presence of 50 μM of etoposide added
directly into the wells. Cells were further incubated with
etoposide for 24 h.
At the end of the incubation, RNA was extracted from
macrophages and RT-qPCR was used to measure M1
and M2 macrophage marker expression (Fig. 7). Incuba-
tion in CO2 independent medium with or without eto-
poside had no effect on macrophage polarity. Indeed, IL-
6 was the only M1 marker clearly affected by the pres-
ence of etoposide. Regarding M2 macrophage markers,
only CCL18 expression was strongly reduced in cells in-
cubated with etoposide. The same experiment was per-
formed on monocultures of macrophages incubated in the
same conditions and the M1 and M2 marker expression
was similar to the one measured in co-cultures (Fig. 8). In-
cubation of pro-inflammatory M1 macrophages in the
presence of etoposide not significantly increased IL-6 and
IL-1ß mRNA expression. This increase is probably due to
p38 MAPK activation by etoposide [5]. Once activated,
p38 MAPK induces TNF-α, IL-ß and IL-6 expression.
Moreover, IL-6 and CXCL10 levels were higher in M1
macrophages in co-culture with HepG2 cells than in
monoculture.
At the same time, protein extraction was performed
on the HepG2 cells in order to measure apoptosis and
how it could be affected by the co-cultured macro-
phages via secreted factors. Western blotting analyses
were performed in order to measure cleaved caspase-3
and cleaved PARP-1 protein abundance (Fig. 9a) and
caspase-3/7 activity was quantified using a fluorogenic
substrate (Fig. 9b). An increased abundance of cleaved
caspase-3 was observed in HepG2 cells incubated in
the presence of M1 macrophages in comparison to
Fig. 6 M2 macrophage secretion of IL-10 and CCL18. The IL-10 and
CCL18 secretion in culture medium by macrophages was measured by
ELISA. Results are expressed as means ± 1 S.D. (n= 3). Statistical analysis
was carried out with a two-way ANOVA test, followed by a Holm-Sidak
post-test. NS: not significantly different. ** or ***: significantly different
from the corresponding control (Ctrl) respectively with p < 0.01 or 0.001;
# or ###: significantly different respectively with p < 0.05 or 0.001.
Statistical analyses were performed on log-transformed data for CCL18
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control cancer cells incubated without macrophages.
The slight increase in PARP-1 protein abundance was how-
ever not significant. M1 macrophages also increased the
caspase activity in etoposide-exposed HepG2 cells. It has
to be noted that a slight increase in HepG2 cell apop-
tosis was observed when cells were incubated with M1
macrophages in the absence of etoposide (data not
shown). When HepG2 cells were incubated with M2
macrophages, cancer cell apoptosis was highly reduced
in comparison to the one measured in control cells. In-
deed, cleaved caspase-3 and cleaved PARP-1 proteins
are much less abundant in cells incubated in the pres-
ence of M2 macrophages. Western blot results were
confirmed by a caspase activity assay.
These results were reproduced in a second cancer
cell line, A549 cells, co-cultured with macrophages
during 24 h before addition of the etoposide and
incubation during 16 h (Fig. 10). The incubation kin-
etic was changed because A549 cells are more sensitive
to etoposide-induced apoptosis than HepG2 cells. M0
macrophages had no effect on the etoposide-induced
HepG2 cell apoptosis (Fig. 9) and no effect on the
etoposide-induced A549 cell apoptosis as measured by
caspase-3 and PARP-1 cleavage (Fig. 10a) and propi-
dium iodine-annexin V-labeling (Fig. 10c). However,
an increase was observed for caspase-3/7 activity ana-
lysis in A549 cells (Fig. 10b), which is indeed no really
consistent with the two other observations. This may
be due to the activity of other caspases than caspase-3
like caspase-7.
In co-culture with A549 cells, the cytotoxic effect of
M1 macrophages was smaller than what was observed
in co-culture with HepG2 cells. However, M1 macro-
phages significantly increased the caspase activity as
Fig. 7 Study of M1 (a) and M2 (b) polarization marker mRNA expression in co-cultured macrophages. Macrophages were co-cultured in indirect
contact with HepG2 cells during 16 h before incubation with or without 50 μM etoposide (+/− e) during 24 h. After the incubation, macrophage
RNA was extracted, retro-transcribed and the mRNA expression of M1 and M2 macrophage markers was studied by RT-qPCR (n = 1)
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well as the percentage of propidium iodide positive
A549 cells (necrotic cells) in comparison to control
cells incubated with etoposide without macrophages
(Fig. 10c). M1 macrophages increased the etoposide-
induced HepG2 cell apoptosis (Fig. 9) as well as the
etoposide-induced A549 cell apoptosis as measured by
Fig. 8 Study of M1 (a) and M2 (b) polarization markers mRNA expression in etoposide-incubated macrophages. THP-1 macrophages were
differentiated (M0) and polarized in M1 and M2 macrophages by respectively 24 h with IFN-γ (20 ng/ml) + LPS (10 pg/ml) (M1) and 72 h with
IL-4 and IL-13 (20 ng/ml each- M2)). Once polarized, they were incubated in CO2-independent medium (+3,75 g D-glucose/l) during 16 h
before incubation with or without 50 μM etoposide (+/− e) during 24 h. After the incubation, mRNA expression of M1 and M2 macrophage
markers was studied by RT-qPCR and normalized by RPS9 expression. Results are expressed as means ± 1 S.D. (n = 3). Statistical analysis was
carried out with the two-way ANOVA test followed by a Holm-Sidak post-test NS: not significantly different. *: significantly different from the
corresponding control with p < 0.05; ## or ###: significantly different respectively with p < 0.01 or 0.001. Statistical analyses were performed
on log-transformed data for all the genes
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caspase-3 activity (Fig. 10b) and propidium iodine-
annexin V-labeling (Fig. 10c). However, no significant
effect was observed on cleaved caspase-3 and cleaved
PARP-1 protein abundance in A549 cells (Fig. 10a),
which is indeed no really consistent with the two other
observations. However, for two western blot analyses
out of the three independent experiments, this effect
was observable.
On the opposite, M2 macrophages displayed a strong
protective effect for all three parameters.
All together, these results showed that M1 and M2
macrophages differentiated and polarized from THP-1
monocytes modulate the apoptotic response to etoposide
of two cancer cell lines, HepG2 and A549 cancer cells.
M1 macrophages had a cytotoxic effect and increased
the etoposide-induced apoptosis. On the opposite, M2
macrophages were protective and decreased the apop-
tosis in cancer cells exposed to this drug.
Using this in vitro model of co-culture, we were able to
reproduce the effects of macrophages observed in clinical
studies or with different in vivo animal models. Many stud-
ies have shown on one hand an inverse correlation between
macrophage abundance in a tumor and patient prognosis
and survival, and on the other hand a positive correlation
with resistance to chemotherapy [11, 27–29]. In sites of
chronic inflammation where a tumor may develop, macro-
phages have a M1 phenotype [30]. M1 macrophages are
cytotoxic for pathogens and tumor cells. Their tumoricidal
activity was related to their ability to secrete reactive nitro-
gen and oxygen species and pro-inflammatory cytokines
[7]. THP-1 M1 macrophages polarized after 24 h incuba-
tion with 10 pg/ml of LPS and 20 ng/ml IFN-γ and incu-
bated with HepG2 or A549 cells were able to increase the
apoptosis of cancer cells induced by etoposide.
In malignant tumors, macrophages exhibit predom-
inantly an M2-like phenotype [3, 31, 32]. M2 macro-
phages improve tumor cell growth and survival by
secretion of many growth factors like EGF, members of
the FGF family, TGF-ß or VEGF (vascular endothelial
growth factor) [10, 33]. Many soluble factors present in
Fig. 9 Modulation of HepG2 cell apoptosis induced by etoposide by co-cultured M0, M1 and M2 macrophages. Macrophages were co-cultured in indirect
contact with HepG2 cells during 16 h before incubation with or without 50 μM etoposide (+/− e) during 24 h. (a) HepG2 cell proteins were extracted and
PARP-1 and caspase-3 protein abundance was assessed by western blotting using specific antibodies. ß-actin was used as loading control. Graphs
represent the quantification of cleaved PARP-1 and cleaved caspase-3 abundance normalized by the corresponding ß-actin in three independent
experiences. Results are expressed as mean ± 1 S.D. (n = 3). (b) After the incubation with etoposide, caspase-3 and-7 activity was assayed in HepG2 cells
by measuring the fluorescence intensity of free AFC released from the cleavage of Ac-DEVD-AFC. Results are expressed in relative caspase-3/-7 activity as
mean ± 1 S.D. (n= 3). Statistical analysis was carried out with the one-way ANOVA test followed by a Holm-Sidak post-test. NS: no significantly different
from control cells incubated with etoposide; * or **: significantly different from control cells incubated with etoposide respectively with p < 0.05 or 0.01
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the tumor microenvironment and secreted by macro-
phages have already been described to decrease cancer
cell response to chemotherapy like IL-1ß [34, 35],
VEGF [36], TGF-ß [37], IL-4 [38] as well as cathepsins
B and S [11]. However, not all of these genes are typical
M2 macrophage markers. Indeed, IL-1ß is up regulated in
M1 macrophages and cathepsin S is slightly up regulated
after IFN-γ and LPS stimulation (data not shown).
THP-1 M2 macrophages polarized by 72 h incubation
with 20 ng/ml of IL-4 and IL-13 and incubated with HepG2
Fig. 10 Modulation of A549 cell apoptosis induced by etoposide by co-cultured M0, M1 and M2 macrophages. Macrophages were co-cultured in
indirect contact with A549 cells during 24 h before incubation with or without 50 μM etoposide (+/− e) during 16 h. (a) A549 cell proteins were
extracted and PARP-1 and caspase-3 protein abundance was assessed by western blotting using specific antibodies. α-tubulin was used as loading
control. Graphs represent the quantification of cleaved PARP-1 and cleaved caspase-3 abundance normalized by the corresponding α-tubulin in three
independent experiences. Results are expressed as mean ± 1 S.D. (n = 3). (b) After the incubation with etoposide, caspase-3 and-7 activity was assayed
in A549 cells by measuring the fluorescence intensity of free AFC released from the cleavage of Ac-DEVD-AFC. Results are expressed in relative
caspase-3/-7 activity as mean ± 1 S.D. (n = 3). (c) After the incubation with macrophages, A549 cells were detached and stained with Annexin
V-FITC and propidium iodide before fluorescence analysis by flow cytometry. The percentage of cells in the four different quadrants was
calculated and the results present in different histograms where viable cells are Annexin V-/PI-, apoptotic cells Annexin V+/PI- and necrotic cells
are PI +. Results are present as mean ± 1 S.D. (n = 3). Statistical analysis was carried out with the one-way ANOVA test followed by a Holm-Sidak
post-test. NS: no significantly different from control cells incubated with etoposide; *, ** or ***: significantly different from control cells
incubated with etoposide respectively with p < 0.05, 0.01 or 0.001
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or A549 cells highly reduced the etoposide-induced apop-
tosis. It has to be noted that, in human macrophages, NO
production is not modulated by polarization as it is de-
scribed for murine macrophages [5]. This is important
since etoposide has been shown to be chemically modified
by NO-derived species and forms products with reduced
toxic activity [39].
Etoposide at the concentration used in this work did not
influence macrophage polarization. Moreover macrophage
expression profiles were very similar between co-culture
and monoculture experiments performed in the same incu-
bation conditions. It means that cancer cells have no im-
pact on THP-1 macrophage polarization after incubation
with etoposide. Results from Weigert et al. [40] showed
that when primary macrophages were incubated in direct
co-culture with MCF-7 cells, they produced TNF-α that in-
duced MCF-7 cell apoptosis. Apoptotic cells released
sphingosine-1-phosphate (S1P), which caused a macro-
phage phenotypic switch from M1 to M2. THP-1 M0 mac-
rophages did not induce cancer cell apoptosis in our co-
culture system and no phenotypic switch was observed
after co-culture with etoposide. However, the kinetic used
in that study was more than 3 days longer than ours. The
same research group also described that S1P can favor
macrophage survival after etoposide incubation [39]. We
did not study the impact of S1P on THP-1 macrophage
survival, which seemed unaffected by 24 h incubation with
50 μM of etoposide, but we did it on HepG2 cell response
to etoposide. S1P had no effect on etoposide-induced
apoptosis of HepG2 cells (data not shown). Hence, the
differential effects we observed were not due to a shift
from one phenotype to the other.
Our model is original because it uses THP-1 differenti-
ated macrophages, which are easy to obtain, differentiate
and polarize. M1 and M2 THP-1 macrophages have the
same expression profiles than polarized primary macro-
phages. We studied the influence of macrophages on can-
cer cell response to etoposide. Macrophage pre-incubation
with cancer cells was needed to obtain a protective effect
of M2 macrophages on the etoposide-induced apoptosis.
It means that the two cell populations have to exchange
soluble factors, which will activate pro-survival pathways
allowing cancer cells to resist to the etoposide-induced
apoptosis. This model is a great tool to study the influence
of a specific pathway in the protective or cytotoxic effect
of macrophages on cancer cells. We used it to study the
influence of the COX-I pathway (up-regulated in the M2
macrophages, data not shown) and no effect of COX-I in-
hibition was observed on the protective effect of M2
macrophages.
Conclusion
In conclusion, we developed an easy, reproducible and
well-characterized model of differentiated THP-1
monocytes polarized into M1 and M2 macrophages.
Using this model, we demonstrated that M1 and M2
macrophages exerted opposite effects on cancer cell re-
sponse to a chemotherapeutic drug.
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